Therapeutic challenges posed by critical drug-drug interactions in cystic fibrosis

Epidemiology of Polypharmacy and Potential Drug–Drug Interactions Among Pediatric Patients in ICUs of U.S. Children’s Hospitals*

(2016) Dingwei Dai et al.   Pediatric Critical Care Medicine

Highlights from the 2015 North American Cystic Fibrosis Conference

(2016) Edith T. Zemanick et al.   PEDIATRIC PULMONOLOGY

Drug interactions and treatment burden as survival improves

(2015) David P. Nichols et al.   CURRENT OPINION IN PULMONARY MEDICINE

Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features

(2015) Consuelo Pedrós et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Drug–drug interactions and safety of linezolid, tedizolid, and other oxazolidinones

(2015) Antonios Douros et al.   Expert Opinion on Drug Metabolism & Toxicology

A Case Series on the Heightened Autonomic Response due to Guanfacine and Amphetamine Interaction

(2015) Edward C. Gaiser et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

An unusual cause of growth failure in cystic fibrosis: A salutary reminder of the interaction between glucocorticoids and cytochrome P450 inhibiting medication

(2015) Benjamin B. Albert et al.   Journal of Cystic Fibrosis

Tackling the increasing complexity of CF care

(2015) Gregory S. Sawicki et al.   PEDIATRIC PULMONOLOGY

Improving complex medical care while awaiting next-generation CFTR potentiators and correctors: The current pipeline of therapeutics

(2015) Jennifer L. Goralski et al.   PEDIATRIC PULMONOLOGY

Ivacaftor therapy in siblings with cystic fibrosis-the potential implications of Itraconazole in dosage and efficacy

(2015) M.J. Harrison et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

A Review of the Pathophysiology, Etiology, and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)

(2014) Alok Sharma et al.   ANNALS OF PHARMACOTHERAPY

Clinical drug-drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P-glycoprotein

(2014) Sarah M. Robertson et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Potential Drug-Drug Interactions in Infant, Child, and Adolescent Patients in Children's Hospitals

(2014) J. Feinstein et al.   PEDIATRICS

Prevalence and Risk of Potential Cytochrome P450–Mediated Drug-Drug Interactions in Older Hospitalized Patients with Polypharmacy

(2013) Julie Doan et al.   ANNALS OF PHARMACOTHERAPY

In Vitro,In Vivo, and Clinical Studies of Tedizolid To Assess the Potential for Peripheral or Central Monoamine Oxidase Interactions

(2013) S. Flanagan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment complexity in cystic fibrosis: Trends over time and associations with site-specific outcomes

(2013) Gregory S. Sawicki et al.   Journal of Cystic Fibrosis

Polypharmacy With Common Diseases in Hospitalized Elderly Patients

(2012) Fumihiro Mizokami et al.   American Journal Geriatric Pharmacotherapy

Factors Leading to Excessive Polypharmacy

(2012) Bo Hovstadius et al.   CLINICS IN GERIATRIC MEDICINE

Potential Serious Adverse Interactions Between Linezolid and Atomoxetine

(2012) Arpit Aggarwal et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Itraconazole and inhaled fluticasone causing hypothalamic–pituitary–adrenal axis suppression in adults with cystic fibrosis

(2012) Francis J. Gilchrist et al.   Journal of Cystic Fibrosis

Azithromycin and the Risk of Cardiovascular Death

(2012) Wayne A. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rapid Onset of Iatrogenic Adrenal Insufficiency in a Patient with Cystic Fibrosis–Related Liver Disease Treated with Inhaled Corticosteroids and a Moderate CYP3A4 Inhibitor

(2011) Wynton C Hoover et al.   ANNALS OF PHARMACOTHERAPY

Prevalence of Polypharmacy Exposure Among Hospitalized Children in the United States

(2011) Chris Feudtner   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data

(2011) Jill M. Butterfield et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Idiosyncratic Liver Failure Probably Associated with Atomoxetine: A Case Report

(2011) Ayten Erdogan et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents

(2009) Roger J. M. Brüggemann et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetics and Therapeutic Drug Monitoring of Psychotropic Drugs in Pediatrics

(2009) Simona Pichini et al.   THERAPEUTIC DRUG MONITORING

Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers

(2008) G. Krishna et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prescribers??? Knowledge of and Sources of Information for Potential??Drug-Drug Interactions

(2008) Yu Ko et al.   DRUG SAFETY

High treatment burden in adults with cystic fibrosis: Challenges to disease self-management

(2008) Gregory S. Sawicki et al.   Journal of Cystic Fibrosis